Background: Evidence about COVID-19 on cardiac injury was insufficient. Objectives: To summarize available data on clinical manifestations of acute cardiac injury during the COVID-19 outbreak. Methods: A systematic literature search from December 1, 2019 to April, 12, 2020 was made of those databases: Pubmed, Embase, wanfang, CKNI, to identify all observational studies that reported presentation of cardiac injury, including acute cardiac injury, cardiac symptoms, cardiac failure, shock, arrhythmia. A random-effects model was used to pool results. Heterogeneity was assessed using I2. Publication bias was assessed using Egger's test. Results: 3863 confirmed COVID-19 infected patients from 22 studies were included in the meta-analysis. Among the patients, the incidence rate of acute cardiac injury was 18% [95%CI 12–23], chest pain (4% [95%CI 2–5]), chest distress (31% [95%CI 16–47]), and palpitations (4% [95%CI 0–7]) were the most common clinical symptoms related to acute cardiac injury. The incidence with heart failure was 22% [95%CI 17–28], the incidence with shock was 9% [95%CI 3–14], and the incidence with arrhythmia was 13% [95%CI 8–19]. Conclusions: Acute cardiac injury without clinical symptoms should be paid more attention among the confirmed COVID-19 infected patients. In addition, this highlights the need to effectively monitor heart health to prevent the cardiac complications (cardiac failure, shock, arrhythmia) in patients infected with COVID-19.
| Published in | International Journal of Infectious Diseases and Therapy (Volume 5, Issue 4) |
| DOI | 10.11648/j.ijidt.20200504.16 |
| Page(s) | 136-144 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2024. Published by Science Publishing Group |
COVID-19, Cardiac Injury, Coronavirus, Chest Pain, Acute Cardiac Injury, Cardiac Failure, Shock, Arrhythmia
| [1] | Yu H, Yang H, Liu JP (2008) Reporting methods of expert clinical examination and experience——design and quality evaluation of case series. Chinese Medicine Journal (05): 407-410. |
| [2] | Chen X, Tong J, Xiang Jh, Hu JJ. Retrospective study on the epidemiological characteristics of 139 patients with novel coronavirus pneumonia on the effects of Severity. Chongqing Medicine1-9. http://kns.cnki.net/kcms/detail/50.1097. R.20200313.1537.004.html. |
| [3] | Xiang TX, Liu JM, Xu F, Chen N, Liu Y, Qian KJ, Zhang W. Analysis of clinical characteristics of 49 patients with Novel Coronavirus Pneumonia in Jiangxi province. Chinese Journal of Respiratory and Critical Care Medicine. 2020, 19 (02): 154-160. |
| [4] | Feng Y, Ling Y, Bai T, Xie Y, Huang J, Li J, Xiong W, Yang D, Chen R, Lu F, Lu Y, Liu X, Chen Y, Li X, Li Y, Summah HD, Lin H, Yan J, Zhou M, Lu H, Qu J. COVID-19 with Different Severities: A Multicenter Study of Clinical Features. Am J Respir Crit Care Med. 2020 Jun 1; 201 (11): 1380-1388. doi: 10.1164/rccm.202002-0445OC. |
| [5] | Yang W, Cao Q, Qin L, Wang X, Cheng Z, Pan A, Dai J, Sun Q, Zhao F, Qu J, Yan, F. Clinical characteristics and imaging manifestations of the 2019 novel coronavirus Disease (COVID-19): A multi-center study in Wenzhou city, Zhejiang, China. J Infect, 80 (4): 388-393. |
| [6] | Jia J, Hu X, Yang F, Song X, Dong L, Zhang J, Jiang F, Gao R. Epidemiological Characteristics on the Clustering Nature of COVID-19 in Qingdao City, 2020: A Descriptive Analysis. Disaster Med Public Health Prep. 2020 Mar 31: 1-5. doi: 10.1017/dmp.2020.59. |
| [7] | Mo P, Xing Y, Xiao Y, Deng L, Zhao Q, Wang H, Xiong Y, Cheng Z, Gao S, Liang K, Luo M, Chen T, Song S, Ma Z, Chen X, Zheng R, Cao Q, Wang F, Zhang, Y. Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China [published online ahead of print, 2020 Mar 16]. Clin Infect Dis. Ciaa 270. doi: 10.1093/cid/ciaa270. |
| [8] | Wu J, Liu J, Zhao X, Liu C, Wang W, Wang D, Xu W, Zhang C, Yu J, Jiang B, Cao H, Li L. Clinical Characteristics of Imported Cases of COVID-19 in Jiangsu Province: A Multicenter Descriptive Study [published online ahead of print, 2020 Feb 29]. Clin Infect Dis. ciaa199. doi: 10.1093/cid/ciaa199. |
| [9] | Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y Wei Y, Xia J, Yu T, Zhang X, Zhang L. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 395 (10223): 507-513. doi: 10.1016/S0140-6736(20)30211-7. |
| [10] | Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China. Jama, 323 (11). |
| [11] | Xiong J, Jiang WL, Zhuo Q, Hu XQ, Liu CY. Clinical characteristics, treatment, and prognosis in 89 cases of COVID-2019. Medical Journal of Wuhan University. 2020, 41 (04), 542-546 DOI: 10.14188/j.1671-8852.2020.0103. |
| [12] | Zhang W, Hou W, Li TZ, Li AX, Pan W, Jin RH, Liang LC, Hu ZJ. Clinical characteristics of 74 hospitalized patients with COVID-19, Journal of Capital Medical University. 2020, 41 (2): 161-167. DOI: 10.3969/j.issn.1006-7795.2020.02.003. |
| [13] | Cao J, Tu WJ, Cheng W, Yu L, Liu YK, Hu X, Liu Q. Clinical Features and Short-term Outcomes of 102 Patients with Coronavirus Disease 2019 in Wuhan, China. Clin Infect Dis. 2020 Jul 28; 71 (15): 748-755. doi: 10.1093/cid/ciaa243. |
| [14] | Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao, B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet, 395 (10229): 1054-1062. |
| [15] | Wang L, He W, Yu X, Hu D, Bao M, Liu H, Zhou J, Jiang H. Coronavirus Disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up. J Infect. 2020 Jun; 80 (6): 639-645. doi: 10.1016/j.jinf. 2020.03.019. Epub 2020 Mar 30. |
| [16] | Lei S, Jiang F, Su W, Chen C, Chen J, Mei W, Zhan LY, Jia Y, Zhang L, Liu D, Xia ZY, Xia Z. Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection. EClinicalMedicine. 2020 Apr 5; 21: 100331. doi: 10.1016/j.eclinm.2020.100331. PMID: 32292899; PMCID: PMC7128617. |
| [17] | Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, Gong W, Liu X, Liang J, Zhao Q, Huang H, Yang B, Huang C. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol. e200950. doi: 10.1001/jamacardio.2020.0950. |
| [18] | Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, Wang H, Wan J, Wang X, Lu Z. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020 Jul 1; 5 (7): 811-818. doi: 10.1001/jamacardio.2020.1017. |
| [19] | Li X, Xu S, Yu M, Wang K, Tao Y, Zhou Y, Shi J, Zhou M, Wu, B, Yang Z, Zhang C, Yue J, Zhang Z, Renz H, Liu X, Xie J, Xie M, Zhao J. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan [published online ahead of print, 2020 Apr 12]. J Allergy Clin Immunol. S0091-6749(20)30495-4. doi: 10.1016/j.jaci.2020.04.006. |
| [20] | Liu K, Chen Y, Lin R, Han K. Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients. J Infect. 2020 Jun; 80 (6): e14-e18. doi: 10.1016/j.jinf.2020.03.005. Epub 2020 Mar 27. |
| [21] | Qian GQ, Yang NB, Ding F, Ma AHY, Wang ZY, Shen YF, Shi CW, Lian X. Chu JG, Chen L, Wang ZY, Ren DW, Li GX, Chen XQ, Shen HJ, Chen XM (2020) Epidemiologic and Clinical Characteristics of 91 Hospitalized Patients with COVID-19 in Zhejiang, China: A retrospective, multi-centre case series. QJM. Hcaa 089. doi: 10.1093/qjmed/hcaa089. |
| [22] | Wan S, Xiang Y, Fang W, Zheng Y, Li B, Hu Y, Lang C, Huang D, Sun Q, Xiong Y, Huang X, Lv J, Luo Y, Shen L, Yang H, Huang G, Yang R. Clinical features and treatment of COVID-19 patients in northeast Chongqing. J Med Virol. 2020 Jul; 92 (7): 797-806. doi: 10.1002/jmv.25783. |
| [23] | Chen T, Wu D, Chen H, Yan W, Yang D, Chen G, Ma K, Xu D, Yu H, Wang H, Wang T, Guo W, Chen J, Ding C, Zhang X, Huang J, Han M, Li S, Luo X, Zhao J, Ning Q. Clinical characteristics of 113 deceased patients with coronavirus Disease 2019: retrospective study. Bmj. 368: m1091. Published 2020 Mar 26. doi: 10.1136/bmj.m1091. |
| [24] | Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L, Bi Z, Zhao Y. Prevalence and impact of cardiovascular metabolic Diseases on COVID-19 in China. Clin Res Cardiol. 109 (5): 531-538. doi: 10.1007/s00392-020-01626-9. |
| [25] | Peng W, Gan X, Tan Y, Cao F, Li S. Damage mechanisms of 2019-nCoV infectious Disease to cardiovascular system and advance in treatment. Chin J Nosocomiol. (08): 1177-1182. |
| [26] | Tavazzi G, Pellegrini C, Maurelli M, Belliato M, Sciutti F, Bottazzi A, Sepe PA, Resasco T, Camporotondo R, Bruno R, Baldanti F, Paolucci S, Pelenghi S, Iotti GA, Mojoli F, Arbustini E. Myocardial localization of coronavirus in COVID-19 cardiogenic shock. Eur J Heart Fail. 2020 May; 22 (5): 911-915. doi: 10.1002/ejhf.1828. Epub 2020 Apr 11. PMID: 32275347; PMCID: PMC7262276. |
| [27] | Inciardi RM, Lupi L, Zaccone G, Italia L, Raffo M, Tomasoni D, Cani DS, Cerini M, Farina D, Gavazzi E, Maroldi R, Adamo M, Ammirati E, Sinagra G, Lombardi CM, Metra M. Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020 Jul 1; 5 (7): 819-824. doi: 10.1001/jamacardio.2020.1096. |
| [28] | Madjid M, Connolly AT, Nabutovsky Y, Safavi-Naeini P, Razavi M, Miller CC. Effect of high influenza activity on risk of ventricular arrhythmias requiring therapy in patients with implantable cardiac defibrillators and cardiac resynchronization therapy defibrillators. Am J Cardiol. 2019; 124: 44-50. |
APA Style
Mingyan Gong, Jun Guo. (2020). Clinical Manifestations of Myocardial Injury Associated with the 2019 Novel Coronavirus Disease in Chinese Population: A Meta-analysis. International Journal of Infectious Diseases and Therapy, 5(4), 136-144. https://doi.org/10.11648/j.ijidt.20200504.16
ACS Style
Mingyan Gong; Jun Guo. Clinical Manifestations of Myocardial Injury Associated with the 2019 Novel Coronavirus Disease in Chinese Population: A Meta-analysis. Int. J. Infect. Dis. Ther. 2020, 5(4), 136-144. doi: 10.11648/j.ijidt.20200504.16
AMA Style
Mingyan Gong, Jun Guo. Clinical Manifestations of Myocardial Injury Associated with the 2019 Novel Coronavirus Disease in Chinese Population: A Meta-analysis. Int J Infect Dis Ther. 2020;5(4):136-144. doi: 10.11648/j.ijidt.20200504.16
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.ijidt.20200504.16,
author = {Mingyan Gong and Jun Guo},
title = {Clinical Manifestations of Myocardial Injury Associated with the 2019 Novel Coronavirus Disease in Chinese Population: A Meta-analysis},
journal = {International Journal of Infectious Diseases and Therapy},
volume = {5},
number = {4},
pages = {136-144},
doi = {10.11648/j.ijidt.20200504.16},
url = {https://doi.org/10.11648/j.ijidt.20200504.16},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijidt.20200504.16},
abstract = {Background: Evidence about COVID-19 on cardiac injury was insufficient. Objectives: To summarize available data on clinical manifestations of acute cardiac injury during the COVID-19 outbreak. Methods: A systematic literature search from December 1, 2019 to April, 12, 2020 was made of those databases: Pubmed, Embase, wanfang, CKNI, to identify all observational studies that reported presentation of cardiac injury, including acute cardiac injury, cardiac symptoms, cardiac failure, shock, arrhythmia. A random-effects model was used to pool results. Heterogeneity was assessed using I2. Publication bias was assessed using Egger's test. Results: 3863 confirmed COVID-19 infected patients from 22 studies were included in the meta-analysis. Among the patients, the incidence rate of acute cardiac injury was 18% [95%CI 12–23], chest pain (4% [95%CI 2–5]), chest distress (31% [95%CI 16–47]), and palpitations (4% [95%CI 0–7]) were the most common clinical symptoms related to acute cardiac injury. The incidence with heart failure was 22% [95%CI 17–28], the incidence with shock was 9% [95%CI 3–14], and the incidence with arrhythmia was 13% [95%CI 8–19]. Conclusions: Acute cardiac injury without clinical symptoms should be paid more attention among the confirmed COVID-19 infected patients. In addition, this highlights the need to effectively monitor heart health to prevent the cardiac complications (cardiac failure, shock, arrhythmia) in patients infected with COVID-19.},
year = {2020}
}
TY - JOUR T1 - Clinical Manifestations of Myocardial Injury Associated with the 2019 Novel Coronavirus Disease in Chinese Population: A Meta-analysis AU - Mingyan Gong AU - Jun Guo Y1 - 2020/12/11 PY - 2020 N1 - https://doi.org/10.11648/j.ijidt.20200504.16 DO - 10.11648/j.ijidt.20200504.16 T2 - International Journal of Infectious Diseases and Therapy JF - International Journal of Infectious Diseases and Therapy JO - International Journal of Infectious Diseases and Therapy SP - 136 EP - 144 PB - Science Publishing Group SN - 2578-966X UR - https://doi.org/10.11648/j.ijidt.20200504.16 AB - Background: Evidence about COVID-19 on cardiac injury was insufficient. Objectives: To summarize available data on clinical manifestations of acute cardiac injury during the COVID-19 outbreak. Methods: A systematic literature search from December 1, 2019 to April, 12, 2020 was made of those databases: Pubmed, Embase, wanfang, CKNI, to identify all observational studies that reported presentation of cardiac injury, including acute cardiac injury, cardiac symptoms, cardiac failure, shock, arrhythmia. A random-effects model was used to pool results. Heterogeneity was assessed using I2. Publication bias was assessed using Egger's test. Results: 3863 confirmed COVID-19 infected patients from 22 studies were included in the meta-analysis. Among the patients, the incidence rate of acute cardiac injury was 18% [95%CI 12–23], chest pain (4% [95%CI 2–5]), chest distress (31% [95%CI 16–47]), and palpitations (4% [95%CI 0–7]) were the most common clinical symptoms related to acute cardiac injury. The incidence with heart failure was 22% [95%CI 17–28], the incidence with shock was 9% [95%CI 3–14], and the incidence with arrhythmia was 13% [95%CI 8–19]. Conclusions: Acute cardiac injury without clinical symptoms should be paid more attention among the confirmed COVID-19 infected patients. In addition, this highlights the need to effectively monitor heart health to prevent the cardiac complications (cardiac failure, shock, arrhythmia) in patients infected with COVID-19. VL - 5 IS - 4 ER -
Email: